- The key vendors in the global high-content screening market 2015-2019 are Becton, Dickinson and Co., GE Healthcare, Danaher Corp., PerkinElmer Inc., and Thermo Fisher Scientific Inc.
London, 30 June 2015: Technavio, an independent tech-focused global research firm, has announced the publication of its market research report on the global high-content screening market 2015-2019. A key trend observed in this market is the rapid development of personalized medicines. Sophisticated high-content screening (HCS) systems help in the rapid, large-scale, quantitative assessment of cellular biology procedures. Genomic testing helps in identifying cancerous traits, and its response to specific drugs are extensively used to develop personalized medicine. This market is expected to grow at a CAGR of 11.53% during the forecast period of 2014-2019.
Market growth is driven by the increasing usage of novel florescent probes that are suitable for live cell imaging applications, advanced informatics and image analysis instruments, and improved reagents for cellular analysis. Various government initiatives related to cell-based research and the incorporation of genomic and proteomic technologies into cellomics drive the demand for HCS systems. Also, technologies that focus on enhancing the relevance of biological data through the screening of tissues, organs, and other multicellular assemblies will lead to the mass utilization of HCS in the future.
“Important discoveries in the biomedical field through the use of HCS have already been implemented in clinical diagnostics, especially in oncology and neurology. The identification of oncogenic variants via genomic testing technologies and their response to specific drugs are extensively used to develop personalized medicine,” says Faisal Ghaus, Vice President of Technavio Research.
“Both drug-target verification and pathway detection in neuroscience research help in the drug discovery for neurodegenerative diseases. These advances enable the analysis and generation of big data in applied life sciences research.”
To define the market conditions in the next 3-4 years, Technavio analysts have conducted in-depth analysis of the impact of market drivers, challenges, and trends featuring data on product segmentations, vendor shares, growth rate by revenue, and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
